Real-Time PCR in faecal samples of Triatoma infestans obtained by xenodiagnosis: proposal for an exogenous internal control
© Bravo et al; licensee BioMed Central Ltd. 2012
Received: 10 January 2012
Accepted: 26 March 2012
Published: 26 March 2012
The polymerase chain reaction (PCR) has proved to be a sensitive technique to detect Trypanosoma cruzi in the chronic phase of Chagas disease, which is characterized by low and fluctuating parasitemia. Another technique proposed for parasitological diagnosis in this phase of infection combines a microscopic search for motile trypomastigote forms in faecal samples (FS) obtained by xenodiagnosis (XD) with conventional PCR (XD-PCR). In this study we evaluate the use of human blood DNA as an exogenous internal control (EIC) for real time PCR (qPCR) combined with XD (XD-qPCR) using chromosome 12 (X12) detection.
None of the FS-XD evaluated by qPCR amplified for X12. Nevertheless, all the EIC-FS-XD mixtures amplified for X12.
We determined that X12 is useful as an EIC for XD-qPCR because we showed that the FS-XD does not contain human DNA after 30 or more days of XD incubation. This information is relevant for research on T. cruzi by XD-qPCR since it allows ruling out inhibition and false negative results due to DNA loss during the process of extraction and purification.
The application of the polymerase chain reaction (PCR) has allowed the detection of Trypanosoma cruzi in several biological samples obtained from insect vectors and mammalian hosts [1–5]; however, it is a qualitative technique. By contrast, the real-time PCR (qPCR) technique allows detection and quantification of T. cruzi parasitic loads, which is particularly important in studies where the effectiveness of chemotherapy is being evaluated [6, 7].
Xenodiagnosis (XD) is another non-routine parasitological method, which uses biological vectors to amplify T. cruzi[8, 9] and has shown good sensitivity and precocity when combined with conventional PCR . The aim of this study is to evaluate the utility of a human DNA fragment as an exogenous internal control (EIC), to be used as a positive control of DNA extraction and as a qPCR inhibitor alert in studies of detection of T. cruzi by qPCR in faecal samples (FS) obtained by xenodiagnosis (FS-XD) applied in humans.
DNA extraction and purification from human blood
All the procedures were carried out in our laboratory. We extracted 5 ml of peripheral blood by venous puncture of an individual serologically negative for Chagas disease, determined by an ELISA Chagas III kit (GrupoBios SA, Chile) and by indirect immunofluorescence IgG (IFI-IgG in-house) tests. The sample was received in 5 ml of guanidine-HCl 6 M EDTA 0.2 M, incubated at 98°C for 15 min in a double boiler and stored at 4°C. Extraction and purification were performed with an initial volume of 200 μl of blood-buffer mixture, according to the indications of the FavorPrep™ Blood Genomic DNA Extraction Mini Kit (Favorgen), with some modifications. We eluted twice with 50 μl of elution buffer that was previously incubated for 10 min at 60°C. Elution volume was 100 μl and samples were stored at -20°C until amplification assays.
Quantification of human DNA
After extraction and purification, total DNA quantification was carried out using AccuBlue™ High Sensitivity dsDNA Quantitation Kit (Biotium Inc.) and the qPCR instrument Mx3000P (Agilent Technologies) as detector devices. Briefly, the protocol started by mixing the dsDNA Quantitation Solution and the 100x Enhancer Solution in a 100:1 proportion. Then 40 μl of this mixture was loaded in each tube. After this step, 2 μl of DNA sample or 2 μl from each of the eight DNA standards provided by the kit (0, 0.5, 1, 2, 4, 6, 8 and 10 ng/μl dsDNA) were added to each tube. Finally, after mixing and incubating for 5 min in darkness at 25°C, the samples were scanned using the Quantitative Plate Read and the FAM filter of the Mx3000P instrument.
Obtaining faecal samples of Triatoma infestans
Under informed consent approved by the Ethics Committee of the Faculty of Medicine, University of Chile, XD assays were applied using the technique described by Schenone . Two XD boxes, each containing seven infection-free T. infestans nymphs of instars III and IV, were placed for 20-30 min on the forearm of 6 individuals with positive ELISA and IFI-IgG tests for Chagas disease. The boxes were maintained at 27°C and after 30, 60 and 90 days of incubation, the FS of each insect were microscopically examined to detect trypomastigote forms of T. cruzi. Thus 3 FS-XD at 30, 60, 90 days were analyzed for each patient (n = 6), resulting in a total of 18 FS-XD. The FS-XD were received in 500 μl PBS buffer pH 7.2, incubated for 15 min at 98°C in a double boiler and centrifuged for 3 min at 3500 rpm. A total of 200 μl of supernatant from each FS-XD was collected and stored at -20°C until use .
Purification of Triatoma infestans faecal samples
qPCR protocol for chromosome 12 (X12)
X12 primers were designed using AmplifX v.1.5.4 (N.Jullien) software, and then compared with Nucleotide BLAST (National Library of Medicine) to discount any other unspecific amplification (N. Nazal, personal communication). The N1X12 forward (5'-AGCTGGCTAGACTGTCAT-3') and N2X12 reverse (5'-CTTTGCCGTTGAAGCTTG-3') primers were used at a concentration of 1 μM (Integrated DNA Technologies) and the qPCR reaction was carried out using Brilliant III Ultra-Fast SYBR® Green QPCR Master Mix (Agilent Technologies), Molecular Biology Grade water (Mo Bio Laboratories, Inc.), and 2 μL of DNA isolated from FS-XD with or without EIC, in a final volume of 20 μL. The same qPCR reaction was carried out for 5-fold serial dilutions of DNA extracted from blood of a healthy human mixed with DNA of FS free of infection from T.infestans, to estimate the sensitivity and the efficiency of the X12-qPCR reaction and to determine the optimal human blood DNA concentration to use as EIC. The thermal profile included 3 min of pre-incubation at 95°C and 40 amplification cycles (95°C for 5 sec, 65°C for 15 sec and 72°C for 10 sec). The measurement of emitted fluorescence was performed at 72°C at the end of each cycle. After all the amplification cycles a melting curve was run. The results were analyzed with the MxPro v4.1 d (Agilent Technologies) software.
The X12-qPCR reaction for 5-fold serial dilutions of DNA (3, 6, 12, 50 and 100 ng) extracted from human blood negative for T. cruzi (EIC) had an efficiency of 94.4%, a coefficient of determination (R2) of 0.994 and a slope of -3.463 (data not shown). The amplicon generated had an average melting temperature (Tm) of 84.24°C and a threshold cycle (Ct) average of 29.89 (Figure 1A).
All EIC concentrations were tested on FS-XD and showed amplification of the X12-qPCR reaction. By contrast, no sign of amplification was shown in FS-XD without EIC (Figure 1B).
We decided to use 50 ng equivalent of negative human blood DNA as an EIC for FS-XD before the DNA isolating process, given the fact that this quantity had an early qPCR Ct value without diluting excessively the original FS-XD ((29.96, Figure 1B). Moreover, this Ct value was similar to the average Ct obtained in dilutions of human blood DNA (Figure 1A and 1B).
The 18 FS-XD obtained from 6 individuals with Chagas disease without EIC did not amplify for X12 (Figure 1C). Finally, the 18 EIC + FS-XD mixtures amplified in every case, generating an amplicon with an average Tm of 84.31°C; the average Ct value obtained was 30.56 (Figure 1D).
In the search for an internal control system for XD-qPCR, this study allowed us to verify that triatomines are capable of degrading completely the human DNA they consume within 30 days (Figure 1B and 1C). We designed a system of novel primers using a segment of a DNA sequence which codifies for human X12. The Ct value obtained for the amplification of X12 from 50 ng of DNA added to a sample of non-infected triatomine FS was 29.96 (Figure 1A), and 30.56 with a standard deviation of 1.0011 for the 18 EIC-FS-XD studied, which indicates an optimum recovery of the EIC (Figure 1D). Considering two standard deviations as a criterion, all the Ct values obtained by the amplification of X12 were included in this range. Both the qPCR amplicon generated in the reaction for X12 at EIC-FS-XD and the human blood DNA dilutions were the same, since we obtained a similar Tm value in both assays (Figure 1A and 1C).
These original results are relevant for research on T. cruzi by XD-qPCR since they allow ruling out inhibition and false negative results due to DNA loss during the process of extraction and purification. The use of human DNA for the detection of X12 as an EIC of FS obtained by conventional or artificial XD may be useful for the application of FS-qPCR in the parasitological diagnosis of T. cruzi and in evaluation of the efficacy of chemotherapeutic treatment of Chagas disease.
Others applications of SYBR Green-based Real Time targeting kinetoplast DNA in vectors of Leishmania species (Kinetoplastida, Tripanosomatidae) have been recently described. DNA samples from naturally infected Lutzomyia spp. were used as positive controls of reaction for to discriminate among the human pathogenic species representing the most common causative agents of cutaneous and visceral leishmaniasis in Brazilian endemic areas .
This study was funded by FONDECYT Projects 1100768 and 1080445.
- Virreira M, Serrano G, Maldonado L, Svoboda M: Trypanosoma cruzi: typing of genotype (sub) lineages in megacolon samples from Bolivian patients. Acta Trop. 2006, 100: 252-255. 10.1016/j.actatropica.2006.11.005.View ArticlePubMedGoogle Scholar
- Britto C: Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. Mem Inst Oswaldo Cruz. 2009, 104: 122-135.View ArticlePubMedGoogle Scholar
- Botto-Mahan C, Campos R, Acuña-Retamar M, Coronado X, Cattán PE, Solari A: Temporal variation of Trypanosoma cruzi infection in native mammals in Chile. Vector Borne Zoonotic Dis. 2010, 10: 317-319. 10.1089/vbz.2009.0006.View ArticlePubMedGoogle Scholar
- Schijman A, Bisio M, Orellana L, Sued M, Duffy T, Mejia-Jaramillo AM, Cura C, Auter F, Veron V, Qvarnstrom Y, Deborggraeve S, Hijar G, Zulantay I, Lucero RH, Velázquez E, Tellez T, Sánchez-León Z, Galvão L: International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis. 2011, 5: e931-10.1371/journal.pntd.0000931.PubMed CentralView ArticlePubMedGoogle Scholar
- Zulantay I, Apt W, Valencia C, Torres A, Saavedra M, Rodríguez J, Sandoval L, Martínez G, Thieme P, Sepúlveda E: Detection of Trypanosoma cruzi in untreated chagasic patients is improved by using three parasitological methods simultaneously. J Antimicrob Chemother. 2011, 66: 2224-2226. 10.1093/jac/dkr313.View ArticlePubMedGoogle Scholar
- Duffy T, Bisio M, Altcheh J, Burgos JM, Diez M, Schijman AG: Accurate Real-Time PCR strategy for monitoring bloodstream parasitic loads in Chagas disease patients. PLoS Negl Trop Dis. 2009, 3: e419-10.1371/journal.pntd.0000419.PubMed CentralView ArticlePubMedGoogle Scholar
- Cencig S, Coltel N, Truyens C, Carlier Y: Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with Am Bisome. PLoS Negl Trop Dis. 2011, 5: e1216-10.1371/journal.pntd.0001216.PubMed CentralView ArticlePubMedGoogle Scholar
- Castro C, Santos MC, Silveira CA: Comparative study between artificial xenodiagnosis performed immediately and four hours after venous punch. Rev Soc Bras Med Trop. 2004, 37: 128-130. 10.1590/S0037-86822004000200002.View ArticlePubMedGoogle Scholar
- Schenone H: Xenodiagnosis. Mem Inst Oswaldo Cruz. 1999, 94: 289-294.View ArticlePubMedGoogle Scholar
- Zulantay I, Apt W, Gil LC, Rocha C, Mundaca K: The PCR-based detection of Trypanosoma cruzi in the faeces of Triatoma infestans fed on patients with chronic American tripanosomiasis gives higher sensitivity and a quicker results than routine xenodiagnosis. Ann Trop Med Parasitol. 2007, 101: 673-679. 10.1179/136485907X241415.View ArticlePubMedGoogle Scholar
- Pita-Pereira D, Lins R, Oliveira M, Lima R, Pereira B, Moreira O: SYBR Green-based Real-Time PCR targeting kinetoplast DNA can be used to discriminate between the main etiologic agents of Brazilian cutaneous and visceral leishmaniasis. Parasit Vectors. 2012, 5: 15-10.1186/1756-3305-5-15.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.